As the main profibrotic transcription factors, SMAD2 and SMAD3 were activated in DSS-induced chronic colitis, and the increased phosphorylation levels of SMAD2 and SMAD3 were reversed by ME treatment (Figures 6A, G, H). This evidence concerns the gene SMAD3 and Chronic colitis.